Fiaccadori E, Del Canale S, Coffrini E, et al. Hypercapnic-hypoxemic chronic obstructive pulmonary disease (COPD): influence of severity of COPD on nutritional status.
Am J Clin Nutr. 1988;48:680 - 685.
Openbrier DR, Irwin MM, Rogers RM, et al. Nutritional status and lung function in patients with emphysema and chronic bronchitis.
Chest. 1983;83:17 - 22.
Keim NL, Luby MH, Braun SR, et al. Dietary evaluation of outpatients with chronic obstructive pulmonary disease.
J Am Diet Assoc. 1986;86:902 - 906.
Keim NL, Luby MH, Braun SR, et al. Dietary evaluation of outpatients with chronic obstructive pulmonary disease.
J Am Diet Assoc. 1986;86:902 - 906.
Pingleton SK, Harmon GS. Nutritional management in acute respiratory failure.
JAMA. 1987;257:3094 - 3099.
Hauke W, Kohler G, Henneicke-Von Zepelin HH, et al. Esberitox((R)) N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). a multicentric, prospective, double-blind, placebo-controlled study.
Chemotherapy. 2002;48:259 - 266.
Grandjean EM, Berthet P, Ruffmann R, et al. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Clin Ther. 2000;22:209 - 221.
Hansen NCG, Skriver A, Brorsen-Riis L, et al. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis.
Respir Med.
1994;88:531 - 535.
Grassi C, Casali L, Rossi A, et al. A comparison between different methods for detecting bronchial hyperreactivity. Bronchial hyperreactivity: methods of study.
Eur J Respir Dis Suppl.
1980;106:19 - 27.
Grassi C, Morandini GC. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis.
Eur J Clin Pharmacol.
1976;9:393 - 396.
Riise GC, Larsson S, Larsson P, et al. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?
Eur Respir J. 1994;7:94 - 101.
Rasmussen JB, Glennow C. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
Eur Respir J. 1988;1:351 - 355.
Parr GD, Huitson A. Oral fabrol (oral N-acetylcysteine) in chronic bronchitis.
Br J Dis Chest. 1987;81:341 - 348.
Boman G, Bcker U, Larsson S, et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
Eur J Respir Dis. 1983;64:405 - 415.
Verstraeten JM. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparaive clinical trial with N-acetylcysteine, bromhexine and placebo.
Acta Tuberc Pneumol Belg. 1979;70:71 - 80.
Dal Negro R, Pomari G, Zoccatelli O, et al. L-carnitine and rehabilitative respiratory physiokinesitherapy: metabolic and ventilatory response in chronic respiratory insufficiency.
Int J Clin Pharmacol. 1986;24:453 - 456.
Dal Negro R, Turco P, Pomari C, et al. Effects of L-carnitine on physical performance in chronic respiratory insufficiency.
Int J Clin Pharmacol. 1988;26:269 - 272.
Dal Negro R, Zoccatelli D, Pomari C, et al. L-carnitine and physiokinesiotherapy in chronic respiratory insufficiency. Preliminary results.
Clin Trials J.
1985;22:353 - 360.
Fujimoto S, Kurihara N, Hirata K, et al. Effects of coenzymeQ10 administration on pulmonary function and exercise performance in patiens with chronic lung diseases.
Clin Investig. 1993;71:S162 - S166.
Efthimiou J, Mounsey PJ, Benson DN, et al. Effect of carbohydrate rich versus fat rich loads of gas exchange and walking performance in patients with chronic obstructive lung disease.
Thorax. 1992;47:451 - 456.
Angelillo VA, Bedi S, Durfee D, et al. Effects of low and high carbohydrate feedings in ambulatory patients with chronic obstructive pulmonary disease and chronic hypercapnia.
Ann Intern Med. 1985;103:883 - 885.
Frankfort JD, Fischer CE, Stansbury DW, et al. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction.
Chest. 1991;100:792 - 795.
Ulmer WT, Schott D. Chronic obstructive bronchitis. Effect of Gelomyrtol forte in a placebo-controlled double-blind study [in German; English abstract].
Fortschr Med. 1991;109:547 - 550.
Meister R, Wittig T, Beuscher N, et al. Efficacy and tolerability of Myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
Arzneimittelforschung. 1999;49:351 - 358.
Dorow P, Weiss T, Felix R, et al. Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease [in German; English abstract].
Arzneimittelforschung.
1987;37:1378 - 1381.
Singh RB, Niaz MA, Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital-based case-control study.
J Nutr Environ Med.
1995;5:235 - 242.
Schwartz J, Weiss ST. Dietary factors and their relation of respiratory symptoms. The Second National Health and Nutrition Examination Survey.
Am J Epidemiol. 1990;132:67 - 76.
Miedema I, Feskens EJM, Heederik D, et al. Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study.
Am J Epidemiol. 1993;138:37 - 45.
Sridhar MK. Nutrition and lung health: should people at risk chronic obstructive lung disease eat more fruit and vegetables?
BMJ. 1995;310:75 - 76.
Schwartz J, Weiss ST. Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I).
Am J Clin Nutr. 1994;59:110 - 114.
Rautalahti M, Virtamo J, Haukka J, et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms.
Am J Respir Crit Care Med. 1997;156:1447 - 1452.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.